Chromatography reagents market seen doubling by 2032

By AI, Created 4:36 AM UTC, June 02, 2026, /AGP/ – The global chromatography reagents market is projected to grow from $8.75 billion in 2025 to $18.21 billion by 2032, driven by demand from pharmaceuticals, biotechnology, food safety, environmental testing and clinical diagnostics. The report points to rising regulatory pressure, more outsourcing to CROs and CDMOs, and faster adoption of high-purity, sustainable and automated lab workflows.

Why it matters: - Chromatography reagents sit at the center of drug development, quality control, food safety testing, environmental monitoring and clinical diagnostics. - The market’s projected rise from $8.75 billion in 2025 to $18.21 billion by 2032 signals sustained demand for the chemicals that make analytical testing possible. - Growth in high-purity and sustainable reagents also reflects pressure on labs to deliver more precise results with less waste.

What happened: - The global Chromatography Reagents Market was valued at $8.75 billion in 2025 and is projected to reach $18.21 billion by 2032. - The forecast implies an 11.04% compound annual growth rate through 2032. - The report was released June 2, 2026, from Austin, Texas. - A sample of the report is available here. - The full report is available here.

The details: - Chromatography reagents include solvents, buffers, ion-pair reagents, derivatization reagents, standards and reference materials. - Solvents account for a significant share because of heavy use in HPLC and LC-MS workflows. - HPLC remains the dominant chromatography technique because of its use in pharmaceutical analysis, quality control and biological research. - UHPLC adoption is strengthening the HPLC segment. - Pharmaceutical and biotechnology research is the largest application segment because of drug development, biomolecule characterization and compliance testing. - Research laboratories and pharmaceutical manufacturers make up the largest end-user group. - North America leads the market because of its pharmaceutical base, research infrastructure and biotechnology investment. - Asia-Pacific is expected to post the fastest growth during the forecast period. - CROs and CDMOs are increasing reagent consumption as more research and manufacturing work moves to outsourced models. - Emerging economies in Asia-Pacific, Latin America and the Middle East are expanding pharmaceutical manufacturing and lab infrastructure.

Between the lines: - Stricter testing rules from healthcare and food safety regulators are keeping demand steady across multiple industries. - The report points to a shift toward ultra-high-purity solvents, low-background buffers and specialized reagent kits for high-sensitivity and high-throughput systems. - Green chromatography is becoming a competitive theme as suppliers push eco-friendly solvents and lower hazardous chemical use. - Automation, AI-driven data analysis and smart reagent management are reshaping how labs buy and use reagents. - Growth in proteomics, metabolomics, genomics and precision medicine is creating more demand for specialized formulations.

What’s next: - Manufacturers are expected to keep developing reagent blends tuned for next-generation chromatography platforms. - Ready-to-use solutions should gain more traction in pharmaceutical and biotechnology labs that want fewer preparation errors and faster workflows. - LC-MS adoption is likely to keep expanding across pharmaceutical, environmental and clinical applications. - Continued investment in life sciences research and lab modernization should support long-term market growth.